410 Ind. Admin. Code 1-2.5-149

Current through November 6, 2024
Section 410 IAC 1-2.5-149 - Incorporation by reference

Authority: IC 16-19-3-4; IC 16-41-2-1

Affected: IC 16-41-2; IC 16-41-9

Sec. 149.

(a) The following documents are hereby incorporated by reference into this rule:
(1) Centers for Disease Control and Prevention (CDC). Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee (HICPAC); June 2007. Electronic copies of this publication are available at http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf.
(2) CDC. Case Definitions for Infectious Conditions Under Public Health Surveillance. Morbidity and Mortality Weekly Report (MMWR); May 2, 1997; Vol. 46; No. RR-10.
(3) CDC. 2012 Nationally Notifiable Diseases and Conditions and Current Case Definitions. Publication available from the CDC Office of Surveillance, Epidemiology and Laboratory Services, Division of Notifiable Diseases and Healthcare Information, 1600 Clifton Road, Atlanta, Georgia 30333. Electronic copies of this publication are available at http://stacks.cdc.gov/view/cdc/12088/.
(4) CDC. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the HICPAC and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR; October 25, 2002; Vol. 51; No. RR-16.
(5)45 CFR 164.512 (2013).
(6) American Public Health Association (APHA). Control of Communicable Diseases Manual, 20th Edition. Heymann, DL, ed.; 2014. Publication available from the APHA, Publication Sales, P.O. Box 933019, Atlanta, Georgia, 31193-3019. Electronic copies of this publication are available at https://www.apha.org.
(7) CDC. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR; December 17, 2010; Vol. 59; No. RR-12.
(8) CDC. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR; December 30, 2005; Vol. 54; No. RR-17.
(9) CDC. Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR; June 20, 2003; Vol. 52; No. RR-11.
(10) CDC. Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR; December 16, 2005; Vol. 54; No. RR-15.
(11) Centers for Disease Control and Prevention guidelines, Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. MMWR 2011; Volume 60, Pages 1650-1653. (12) American Academy of Pediatrics (AAP). Red Book: 2012 Report of the Committee on Infectious Diseases, 29th edition. Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds.; 2012. Publication available from the AAP, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, 60007-1098.
(13) CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th Edition. Atkinson,W, Wolfe S, Hamborsky J, eds. Publication available from The Public Health Foundation, Publication Sales, P.O. Box 753, Waldorf, Maryland, 206040753.
(14) CDC. Manual for the Surveillance of Vaccine-Preventable Diseases. 5th Edition. Roush SW, McIntyre L, Baldy LM, eds.; 2012. Electronic copies of this publication are available at http://www.cdc.gov/vaccines/pubs/surv-manual/index.html.
(15) CDC. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections, 2012, MMWR; August 10, 2012; Vol. 61; No. 31; 590-594.
(16) World Health Organization (WHO). WHO Guidelines on Hand Hygiene in Health Care. WHO Press: Geneva, Switzerland, 2009.
(17) CDC. Revised definition for HIV Infection, as found in MMWR, Volume 63, Recommendations and Reports No. RR-03, April 11, 2014.
(b) Where the provisions of this rule or the laws of Indiana conflict with matters incorporated by reference, this rule and the laws of Indiana shall control.
(c) All incorporated material is available for public review at the department.
(d) The MMWR series of publications is published by the Office of Surveillance, Epidemiology, and Laboratory Services, CDC, U.S. Department of Health and Human Services, 1600 Clifton Road, Atlanta, Georgia 30333. Electronic copies of most MMWR publications are available at http://www.cdc.gov/MMWR.

410 IAC 1-2.5-149

Indiana State Department of Health; 410 IAC 1-2.5-149; filed 11/25/2015, 2:54 p.m.: 20151223-IR-410150039FRA
Readopted filed 11/12/2021, 8:41 a.m.: 20211208-IR-410210385RFA